Should you buy shares in oil giant BP for its 6% yield? This is what I’d do

Lots of pension fund managers hold BP in their portfolios. Should you?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the BP (LSE: BP) share price at 485p, the forward-looking dividend yield is about 6.4% for 2020. Such a juicy payment must be worth considering for a portfolio focused on income, right?

But for me, there’s a problem. My ideal dividend investment will sport a shareholder payment that rises a little each year. And behind that, there will be a generally rising record of revenue, earnings and cash flow.

I don’t want dividend payments to stall or be interrupted because of weaknesses in the basic financial performance of an underlying business. And truth be told, I hanker after modest capital growth from a gradually rising share price too.

When it all comes together like that, I can sleep easily while holding my dividend-led investments. And I’m happy to nod off for a decade or two without checking share prices while the stock market ‘magic’ happens and my wealth grows.

BP fails my basic tests

In my eyes, BP fails those tests. For example, the dividend has been essentially flat since 2014. And revenue, earnings and cash flow have been all over the place. None of those measures are rising like I want them to, and that reflects in the share price chart.

It’s true that sometimes the shares shoot up and occasionally they plunge. But if you look at the chart back to around the turn of the century (2000), the movement has been predominantly sideways – market action that matches the firm’s financial performance. That’s not what I want at all for any of my investments.

Much of the volatility along the way arises because the price of oil affects the business, which is beyond the directors’ control. Cyclicality is a big characteristic of the underlying business. But I also reckon a larger theme is worth considering when appraising the share for your portfolio – economies of the world are planning to rapidly move away from their reliance on hydrocarbon fuels and products.

Reshaping the business

It’s true that BP has been divesting once-important operations and reshaping itself to change with the times. Divestment announcements in 2019 reached $7.2bn by the third quarter, including the firm’s Alaska operations. And the company is throwing itself into new joint ventures in fuels marketing in India and in electric vehicle charging in China.

Maybe BP will emerge from this period of extended change as a leaner organisation with greater prospects for growth. The dividend could even start to go up again. But in the meantime, the company still relies on its traditional oil-based operations, which I reckon carry great risk.

For example, the firm is still paying costs relating to 2010’s oil blowout disaster in the Gulf of Mexico, which seem to be running at between $2bn and $3bn a year almost 10 years after the event. We can’t discount the possibility of something similar happening again.

I know a lot of pension funds and the like hold BP in their diversified portfolios, but I think, as private investors, we can do better than this one. So I’m avoiding the shares.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »